SFX by Ex Libris Inc.

Title:	Synthesis and pharmacological evaluation of 1-(aminomethyl)-3,4-dihydro-5-hydroxy-1H-2-benzopyrans as dopamine D1 selective ligands
Source:	Journal of Medicinal Chemistry [0022-2623] Michaelides, Michael yr:1991

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Chambers, J. "A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor." Journal of computer-aided molecular design 16.7 (2002): 511-20.
description	2.	McLean, D. "C-(4,5,6-Trimethoxyindan-1-yl)methanamine: A Mescaline Analogue Designed Using a Homology Model of the 5-HT2A Receptor." Journal of medicinal chemistry 49.14 (2006): 4269-4274.
description	3.	Bergman, J. "Agonist efficacy and the behavioral effects of dopamine D-1 receptor ligands: Drug interaction studies in squirrel monkeys." The Journal of pharmacology and experimental therapeutics 276.3 (1996): 942-950.
description	4.	Gerasimov, M. "Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain." Journal of medicinal chemistry 42.20 (1999): 4257-4263.
description	5.	Wyrick, Steven D. "Multiple tritium labeling of (+)-7-chloro-8-hydroxy-1-phenyl-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH23390)." Journal of labelled compounds & radiopharmaceuticals 23.7 (1986): 685-692.
description	6.	Chambers, James J. "Translocation of the 5-alkoxy substituent of 2,5-dialkoxyarylalkylamines to the 6-position: effects on 5-HT2A/2C receptor affinity." Bioorganic & medicinal chemistry letters 12.15 (2002): 1997-1999.
description	7.	Bowie, J. "G-protein-coupled receptor structures were not built in a day." Protein science 18.7 (2009): 1335-1342.
description	8.	McLean, TH. "C-(4,5,6-trimethoxyindan-1-yl)methanamine: A mescaline analogue designed using a homology model of the 5-HT2A receptor. (vol 49, pg 4270, 2006)." Journal of medicinal chemistry 49.25 (2006): 7558-7558.
description	9.	McLean, Thomas H. "1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2A Receptor Agonists." Journal of medicinal chemistry 49.19 (2006): 5794-5803.
description	10.	Mente, S. "Dopamine D1 receptor-agonist interactions: A mutagenesis and homology modeling study." Bioorganic and medicinal chemistry letters 25.10 (2015): 2106-2111.
description	11.	Zhang, W. "The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D-1, D-2, D-3, 5HT(2A) and muscarinic receptors." Psychopharmacology 141.3 (1999): 267-278.
description	12.	Neuvonen, K.. "Effect of 4-substitution on psychotomimetic activity of 2,5-dimethoxy amphetamines as studied by means of different substituent parameter scales." Bioorganic & medicinal chemistry letters 16.13 (2006): 3495-3498.
description	13.	Roth, B. "5-hydroxytryptamine(2)-family receptors (5-hydroxytryptamine(2A), 5-hydroxytryptamine(2B), 5-hydroxytryptamine(2C)): Where structure meets function." Pharmacology & therapeutics 79.3 (1998): 231-257.
description	14.	Goulet, B K K. "D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys." The Journal of pharmacology and experimental therapeutics 292.2 (2000): 714-24.
description	15.	Lainwala S, Shabnam I. "A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations." Advances in neonatal care 5.5 (2005): 265-72.
description	16.	Matsuda, K. "Design, Synthesis, and Characterization of Three Kinds of Ï-Cross-Conjugated Hexacarbenes with High-Spin (S = 6) Ground States." Journal of the American Chemical Society 117.20 (1995): 5550-5560.
description	17.	Von Strandtmann, M. "Acyltryptamines. III. 5-Acetyltryptophan and related compounds." Journal of medicinal chemistry 7.2 (1964): 141-.
description	18.	Hanson, M.A. A. "Discovery of New GPCR Biology: One Receptor Structure at a Time." Structure 17.1 (2009): 8-14.
description	19.	Laban, U. "A novel fluorinated tryptamine with highly potent serotonin 5-HT1a receptor agonist properties." Bioorganic & medicinal chemistry letters 11.6 (2001): 793-795.
description	20.	Chambers, James J. "Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT2A/2C receptor agonists." Journal of medicinal chemistry 44.6 (2001): 1003-1010.